Plasma erythropoietin responses across repeated exposure to normobaric hypoxia in healthy older adults

As we grow older, the brain often faces a quiet challenge: maintaining its sharpness and resilience. Scientists have long looked for ways to support this natural aging process, exploring how the body's own systems might be gently nudged to protect and repair neural tissue. One promising avenue involves the body's reaction to low oxygen levels, a state known as hypoxia. When oxygen drops, the body does not simply panic; it activates specific survival pathways. One of the key players in this response is a hormone called erythropoietin, or EPO. While most people know EPO for its role in stimulating the production of red blood cells to carry oxygen, recent research suggests it may also act as a powerful nutrient for the brain, helping neurons survive and function. The question for researchers is whether this protective signal remains strong when the body is exposed to low oxygen repeatedly over time, or if the system becomes tired and stops responding. Understanding this is crucial for developing safe, non-invasive methods to support brain health in later life.

In a recent study, scientists set out to test exactly how healthy older adults respond to repeated sessions of controlled low oxygen. They gathered nineteen volunteers, all in good health, and guided them through fifteen sessions of sustained hypoxia over a period of three to four weeks. To create this environment, the researchers used a machine to lower the oxygen in the air the participants breathed, carefully adjusting it for each person until their blood oxygen saturation reached a target of about eighty percent. This level was chosen to be a consistent, manageable stimulus that would trigger the body's natural responses without causing distress. The team wanted to see if the body's production of EPO would stay robust or fade away as the weeks passed. To find out, they drew blood from the participants before the sessions began, and then again at intervals for three hours after the first session, a session in the middle of the program, and the very last session.

The results showed a clear and steady pattern. During the first exposure to low oxygen, the participants' bodies responded exactly as expected: their levels of circulating EPO rose sharply, climbing by an average of 6.33 mIU/mL from the start of the session to three hours after it ended. What made this finding significant was that this same strong reaction did not weaken over time. When the researchers looked at the blood samples from the middle and final sessions, the magnitude of the EPO increase was just as high as it had been on day one. The body had not become desensitized; instead, it continued to engage its hypoxia-responsive pathways with the same vigor throughout the entire month-long program. This consistency suggests that repeated exposure to this specific type of low oxygen does not exhaust the system but rather maintains a reliable biological signal.

Beyond the hormone levels, the study also looked at other changes happening inside the body. Using a technique that measures light absorption to track blood flow and oxygen use in the brain, the researchers observed acute shifts in how the prefrontal cortex handled oxygen during the sessions. They also noted temporary changes in blood pressure while the participants were breathing the low-oxygen air. Over the course of the full intervention, the data showed a reduction in resting blood pressure and alterations in blood markers related to iron, which is closely tied to how the body manages oxygen. These findings paint a picture of a body that is actively adapting to the new conditions. The study concludes that sustained normobaric hypoxia can reliably trigger these responses in healthy older adults, keeping the door open for future investigations into how such conditioning might specifically benefit brain function as we age.